Chemogenomics

Genomics based drug discovery, by @leitouran

This is a major research line in the Trypanosomatics Lab, which gives rise to a wide variety of projects:

All these projects have in common the ultimate goal of finding new treatments (drugs) for infectious diseases.

Depending on the approach (computational vs hybrid vs experimental), we may target a large number of human pathogens (as in TDR Targets) or may concentrate only on Chagas Disease (American Trypanosomiasis, caused by Trypanosoma cruzi) or on Sleeping Sickness (Human African Trypanosomiasis, HAT, caused by Trypanosoma brucei).

Please check the pages for these subprojects for more information.

Avatar
Lionel Urán Landaburu
PhD Student

PhD Fellow, teacher and science divulgation enthusiast.

Avatar
Emir Salas Sarduy
Associate Investigator

Passionate about enzymes and drug discovery.

Avatar
María Paula Magariños
Former Trypanosomatics Lab Member (2009 – 2014)

Present address: ChEMBL Group (EMBL-EBI)

Avatar
Fernán Agüero
Principal Investigator, Assistant Professor

Using and generating data to guide discovery of new drugs and diagnostics.

Related